NCT07387198
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07387198
Title Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab (NeoMatryx)
Acronym NeoMatryx
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Nationales Centrum für Tumorerkrankungen RECRUITING Heidelberg Baden-Wurttemberg 69120 Germany Details
Universitätsklinikum Mannheim RECRUITING Mannheim Baden-Wurttemberg 68161 Germany Details
Universitätsklinikum Tübingen RECRUITING Tübingen Baden-Wurttemberg 72076 Germany Details
Universitätsklinikum Regensburg NOT_YET_RECRUITING Regensburg Bavaria 93053 Germany Details
Universitätsklinikum Würzburg RECRUITING Würzburg Bavaria 97080 Germany Details
Universitätsklinikum Hamburg-Eppendorf RECRUITING Hamburg Free and Hanseatic City of Hamburg 20246 Germany Details
Universitätsklinikum Frankfurt NOT_YET_RECRUITING Frankfurt am Main Hesse 60590 Germany Details
Klinikum Bielefeld RECRUITING Bielefeld North Rhine-Westphalia 33647 Germany Details
Universitätsklinikum Köln NOT_YET_RECRUITING Cologne North Rhine-Westphalia 50937 Germany Details
Universitätsklinikum Essen RECRUITING Essen North Rhine-Westphalia 45147 Germany Details
Johannes Wesling Klinikum Minden NOT_YET_RECRUITING Minden North Rhine-Westphalia 32429 Germany Details
Universitätsmedizin Mainz RECRUITING Mainz Rhineland-Palatinate 55131 Germany Details
Universitätsklinikum Leipzig NOT_YET_RECRUITING Leipzig Saxony 04103 Germany Details
Helios Klinikum Erfurt RECRUITING Erfurt Thuringia 99089 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field